List of Xention Limited patents

Patents where

Current Assignee

Name

‌

Xention Limited

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9290511 Thieno-pyrimidines, useful as potassium channel inhibitors	Patent 9290511 was granted and assigned to Xention Limited on March, 2016 by the United States Patent and Trademark Office.	‌ Xention Limited	‌ Xention Limited	United States Patent and Trademark Office	9290511	March 22, 2016
‌ US Patent 7612113 Hydroxy tetrahydro-naphthalenylurea derivatives	Patent 7612113 was granted and assigned to Xention Limited on November, 2009 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	7612113	November 3, 2009
‌ US Patent 7615557 Tetrahydro-naphthalene and urea derivatives	Patent 7615557 was granted and assigned to Xention Limited on November, 2009 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	7615557	November 10, 2009
‌ US Patent 8088826 Tetrahydro-naphthalene derivatives	Patent 8088826 was granted and assigned to Xention Limited on January, 2012 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	8088826	January 3, 2012
‌ US Patent 8173841 Tetrahydro-naphthalene derivatives	Patent 8173841 was granted and assigned to Xention Limited on May, 2012 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	8173841	May 8, 2012
‌ US Patent 8258138 Potassium channel blockers	Patent 8258138 was granted and assigned to Xention Limited on September, 2012 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	8258138	September 4, 2012
‌ US Patent 7456187 Furanopyrimidine compounds as potassium ion channel inhibitors	Patent 7456187 was granted and assigned to Xention Limited on November, 2008 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	7456187	November 25, 2008
‌ US Patent 8759017 High throughput screen	Patent 8759017 was granted and assigned to Xention Limited on June, 2014 by the United States Patent and Trademark Office.	‌ Xention Limited	‌ Xention Limited	United States Patent and Trademark Office	8759017	June 24, 2014
‌ US Patent 8022076 Substituted thieno[2,3-d]pyrimidines as potassium channel inhibitors	Patent 8022076 was granted and assigned to Xention Limited on September, 2011 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	8022076	September 20, 2011
‌ US Patent 7544716 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists	Patent 7544716 was granted and assigned to Xention Limited on June, 2009 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	7544716	June 9, 2009
‌ US Patent 8193215 Thieno[2 3-b]pyridines as potassium channel inhibitors	Patent 8193215 was granted and assigned to Xention Limited on June, 2012 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	8193215	June 5, 2012
‌ US Patent 7576212 Thieno[2,3-B] pyridines as potassium channel inhibitors	Patent 7576212 was granted and assigned to Xention Limited on August, 2009 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	7576212	August 18, 2009
‌ US Patent 7846389 High throughput screen	Patent 7846389 was granted and assigned to Xention Limited on December, 2010 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	7846389	December 7, 2010
‌ US Patent 9249155 Thieno [2, 3-D] pyrimidine derivatives and their use to treat arrhythmia	Patent 9249155 was granted and assigned to Xention Limited on February, 2016 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	9249155	February 2, 2016
‌ US Patent 9073834 Potassium channel blockers	Patent 9073834 was granted and assigned to Xention Limited on July, 2015 by the United States Patent and Trademark Office.	‌ Xention Limited	‌ Xention Limited	United States Patent and Trademark Office	9073834	July 7, 2015
‌ US Patent 8673901 Potassium channel blockers	Patent 8673901 was granted and assigned to Xention Limited on March, 2014 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	8673901	March 18, 2014
‌ US Patent 9216992 Thieno[3,2-c]pyridine potassium channel inhibitors	Patent 9216992 was granted and assigned to Xention Limited on December, 2015 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	9216992	December 22, 2015
‌ US Patent 7381840 Tetrahydro-naphthalene derivatives	Patent 7381840 was granted and assigned to Xention Limited on June, 2008 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	7381840	June 3, 2008
‌ US Patent 8372840 Potassium channel blockers	Patent 8372840 was granted and assigned to Xention Limited on February, 2013 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	8372840	February 12, 2013
‌ US Patent 8449825 High throughput screen	Patent 8449825 was granted and assigned to Xention Limited on May, 2013 by the United States Patent and Trademark Office.		‌ Xention Limited	United States Patent and Trademark Office	8449825	May 28, 2013

20 results

0 selected

20 results

0 selected